SUBSCRIBE
SUBSCRIBE

Preclinical

BIOCEO15 ContraFect CEO Says Lysin, AB Anti-Infectives Are “Game-Changers” in 2015
Drug Development
BIOCEO15: ContraFect CEO Says Lysin, AB Anti-Infectives Are “Game-Changers” in 2015
February 9, 2015
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Two of Roche’s Experimental Parkinson’s Drugs Caused Lung Toxicity in Monkeys
February 6, 2015
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Novartis AG Researchers Claim to Have Discovered “Fountain of Youth” Drug
December 29, 2014
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
AstraZeneca PLC To Test Whether It Can Undo Effects Of Its Own Heart Drug Brilinta
November 13, 2014
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Omeros Corporation Suspends Enrollment In Huntington’s Disease Trial; Stock Down 11.36% At 8:40AM ET On Tuesday
October 21, 2014
 · 
2 min read
Ebola Clinical Trials: Big Name Players In The Ebola Race
BioCapital
Ebola Clinical Trials: Big Name Players In The Ebola Race
October 20, 2014
 · 
12 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Drug Development
GlaxoSmithKline’s Experimental Ebola Vaccine Protects Monkeys For 10 Months
September 8, 2014
 · 
2 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Drug Development
Johnson & Johnson Jumps Into The Ebola Race With Collaboration Of Crucell And Bavarian Nordic; Human Trials To Start In Early 2015
September 4, 2014
 · 
2 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
Drug Development
Ebola-Like Virus Beaten By Tekmira Pharmaceuticals Corporation Drug In Study
August 21, 2014
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Cambridge’s Sarepta Therapeutics Gets A Lift As Shelved Ebola Drug Offers Hope In Crisis
August 7, 2014
 · 
2 min read
Load More
PRESS RELEASES
Press Releases
HKeyBio Debuts HKEY-ExE™ 1.0 to Address Preclinical Bottlenecks in EoE and EgE Drug Development
June 24, 2026
 · 
4 min read
Press Releases
bioAffinity Technologies Reports Positive Preclinical Findings Showing Proprietary Gene Silencing Technology Is Selectively Cytotoxic to Squamous Skin Cancer Cells Without Harming Healthy Cells
June 22, 2026
 · 
7 min read
Press Releases
Traws Pharma Provides Updated Guidance on Influenza Prophylaxis Program
June 22, 2026
 · 
5 min read
Press Releases
Antengene Announces Exclusive License Agreement with MPM BioImpact-Established K2 Therapeutics for ATG-106 and Option for Undisclosed Bispecific TCE
June 21, 2026
 · 
8 min read
Press Releases
Derm-Biome’s DB-006 Demonstrates Superior Efficacy in Preclinical Atopic Dermatitis Study: Reduces Itch, Inflammation, and IgE Levels, Outperforms Leading Topical Drugs
June 19, 2026
 · 
2 min read
Press Releases
Odyssey Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
June 18, 2026
 · 
7 min read
Press Releases
Spot Biosystems Launches with $40 Million Financing and World-First Non-Viral Delivery of Full-Length Dystrophin in Animal Models and Human Patients with DMD
June 18, 2026
 · 
6 min read
Press Releases
Acumen Pharmaceuticals Announces Nomination of Two Enhanced Brain Delivery™ (EBD™) Development Candidates for the Treatment of Alzheimer’s Disease
June 16, 2026
 · 
7 min read
Press Releases
Confo Therapeutics Announces Encouraging Preclinical Data for Post-bariatric Hypoglycemia Candidate CFTX-2034 at ENDO 2026
June 15, 2026
 · 
3 min read
Press Releases
Ethyreal Bio Presents First Preclinical Data on ETHY-001 at ENDO 2026, Demonstrating Complete Blockade of Autoantibody Activation of TSHR and Differentiated Activity in TED
June 15, 2026
 · 
5 min read
Press Releases
Telomir Pharmaceuticals Announces Peer-Reviewed Publication in Biomedicine & Pharmacotherapy Demonstrating Restoration of Insulin Sensitivity with Telomir-Zn in a Preclinical Type 2 Diabetes Model
June 15, 2026
 · 
7 min read
Press Releases
Preclinical Data for OPKO Biologics’ OPK8801001 in Acromegaly Presented at ENDO 2026
June 15, 2026
 · 
4 min read
Press Releases
Promising First-in-Patient Results for ACOU085 (INN: Bimokalner) in Cisplatin-Induced Ototoxicity
June 12, 2026
 · 
2 min read
Press Releases
Recludix Pharma to Present Preclinical Asthma and Dermatitis Data for Oral STAT6 Inhibitor REX-8756 at the European Association of Allergy and Clinical Immunology (EAACI) and Revolutionizing Atopic Dermatitis (RAD) Congresses
June 12, 2026
 · 
3 min read
Press Releases
Cogent Biosciences Announces Preclinical Data from Novel JAK2 V617F Inhibitor at the 2026 European Hematology Association (EHA) Congress
June 12, 2026
 · 
4 min read
Press Releases
Applied Biologics Launches Preclinical Development Program Focused on Osteoarthritis and Other Degenerative Diseases
June 11, 2026
 · 
2 min read
Press Releases
JW Pharmaceutical Presents Preclinical Results and Global Development Strategy for DDC-02, a Novel Therapeutic Candidate for Rare Neurodevelopmental Disorders
June 11, 2026
 · 
4 min read
Press Releases
Paratus Sciences Presents Preclinical and Translational Data on PS-1001, a First-in-Class Pan-Inflammasome Inhibitor, at FOCIS 2026
June 11, 2026
 · 
3 min read
Press Releases
Evaxion presents new preclinical data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia
June 11, 2026
 · 
5 min read
Press Releases
HERVolution Therapeutics Demonstrates Preclinical Proof-of-Concept for Insulin Sensitization Immune Therapy in Metabolic Disease and Announces Exclusive License Agreement with the University of Copenhagen
June 10, 2026
 · 
3 min read
Load More